A Long-term Extension Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-Epileptic Drugs (AEDs)
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Perampanel (Primary)
- Indications Generalised seizures; Partial epilepsies
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 17 Mar 2017 Status changed from active, no longer recruiting to completed.
- 30 Nov 2016 According to an Eisai media release, the company will present results of this study at the 70th American Epilepsy Society (AES) Annual Meeting.
- 02 Dec 2014 New trial record